FDA – medicarereport.org

(Authors Joel Luther, Hagere Yilma, and Irving Washington for The Kaiser Family Foundation published May 14, 2026) KFF’s latest April

Boston Scientific recalls pacemakers after 4 deaths, 2,500 injuries

(By: Mariah Taylor for Becker’s Hospital Review) Boston Scientific issued a recall involving a correction on all 27 Accolade pacemakers

(By: Elizabeth Gregerson for Becker’s Hospital Review) The FDA has launched its first two real-time clinical trials in partnership with

(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to

(By Rob Stein for NPR) The Food and Drug Administration Monday unveiled the details of a new policy designed to

(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to

With drug pricing initiatives pacing the way, American Action Forum (AAF) offers a post today reviewing key changes to the

(By: Elizabeth Casolo for Becker’s Hospital Review) CMS’s proposed Medicare Advantage rule for 2027 includes more leeway for hemp coverage.

(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs

(Source – www.hhs.gov) WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to